Evidence map›Paper›PMID 35438349›Full record

ArticleAIDS and behavior2022

Who is using PrEP on-demand? Factors associated with PrEP use modality among Black and Hispanic/Latino emerging adults.

Antonia E Caba, Taylor Rathus, Esther Burson, Philip A Chan, Lisa A Eaton, Ryan J Watson

Abstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Antonia E CabaDepartment of Human Development and Family Sciences, University of Connecticut, Storrs, CT, US. antonia.caba@uconn.edu.ORCID http://orcid.org/0000-0002-7760-3964
Taylor RathusDepartment of Human Development and Family Sciences, University of Connecticut, Storrs, CT, US.
Esther BursonBronfenbrenner Center for Translational Research, Cornell University, Ithaca, NY, US.
Philip A ChanDepartment of Medicine, Brown University, Providence, RI, US.
Lisa A EatonDepartment of Human Development and Family Sciences, University of Connecticut, Storrs, CT, US.
Ryan J WatsonDepartment of Human Development and Family Sciences, University of Connecticut, Storrs, CT, US.

Funding

The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
PrEP and substance use among sexual minority young adultsK01DA047918 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI WATSON, RYAN J · 2019 to 2023
$952k
NIDA NIH HHS K01 DA047918NIH HHS K01DA04719NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) is a highly efficacious HIV prevention medication, yet Black and Hispanic/Latino sexual minority men's and gender diverse individuals' (SMMGD) PrEP use is limited due to factors such as PrEP barriers and anticipated PrEP stigma. Although most individuals who use PrEP take it as a daily regimen, there is evidence that many SMMGD are interested in using "on-demand" (also known as event-driven or intermittent or 2-1-1) PrEP. We used stepwise multinomial logistic regression to explore factors associated with on-demand, daily, and no PrEP use among 820 Black and Hispanic/Latino SMMGD ages 18-29 in the United States. We found that greater reported PrEP barriers were associated with higher odds of using PrEP on-demand or not using PrEP compared to daily PrEP use. More past 3-month sex partners and greater comfort telling others about PrEP use were associated with lower odds of on-demand compared to daily PrEP use. In addition, compared to daily PrEP use, more past 3-month sex partners, greater comfort telling others about PrEP use, and higher anticipated PrEP stigma were associated with lower odds of no current PrEP use compared to daily PrEP use. Findings may inform clinical practices and interventions to promote PrEP uptake and adherence.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultHispanic or LatinoHomosexuality, MaleHumansMaleSafe SexSexual BehaviorUnited StatesYoung AdultAnti-HIV AgentsBisexualHIV preventionIntermittentOn-demandPrEP

Identifiers

PMID35438349
PMCPMC9912752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.